All-Star Players

Wall Street

Top ARGS Bull/Bear Pitches

Submitted July 08, 2016

Argos Therapeutics, Inc. appears to be doing well in the clinical trials of their "Arcelis" immunotherapy product. Additional funding has done well.While still a risk, I expect this stock to outperform.